Please login to the form below

Not currently logged in
Email:
Password:

EUSA Pharma adds William Crouse to board of directors

Comes as firm hopes to become global leader in biotechnology

EUSA Pharma has appointed William Crouse to its board of directors.

Crouse joins with 50 years of experience in the life sciences industry with his most recent role being general partner at Healthcare Venture, one of the world's largest venture capital firms specialising in biotechnology.

Prior to this, in his many roles over 30 years he has worked in the diagnostics industry, international operations, strategic planning, acquisitions, new product development and sales and marketing.

He said: “It's an honour to join EUSA and to help this ambitious company become a major force in the speciality field.

“Having worked with many of the EUSA team previously, I am confident the company has the capabilities and infrastructure in place to rapidly become a leading player in the sector.”

Bryan Morton, executive chairman at EUSA Pharma, said: “We have great ambitions for EUSA, and plan to grow our existing profitable business through acquisition and in-licensing.

“Bill's extensive experience and strategic insight will be a huge asset as we transform our business into a leading transatlantic speciality commercialization company.”

9th September 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics